期刊文献+

老年糖尿病患者经皮冠状动脉介入术后发生造影剂肾病的危险因素分析 被引量:4

Analysis of Risk Factors for Contrast Induced Nephropathy after Percutaneous Coronary Intervention in Elderly Diabetic Patients
暂未订购
导出
摘要 目的:探讨老年糖尿病患者经皮冠状动脉介入术后发生造影剂肾病的危险因素。方法:选取2018年1-12月在笔者所在医院心内科行PCI术的257例糖尿病合并急性冠状动脉综合征患者作为研究对象,根据是否存在造影剂肾病分为两组,将不存在造影剂肾病的207例作为对照组,发生造影剂肾病的50例作为观察组,比较两组的年龄、性别、体重指数(BMI)、脉压、高血压病、血糖水平、实验室数据、急诊PCI、术前用药等指标,应用Logistic回归分析筛选可能的危险因素。结果:(1)两组患者年龄、性别、体重指数(BMI)、脉压、空腹血糖、餐后2 h血糖、糖基化血红蛋白、血脂、D-二聚体、手术时间、造影剂剂量等方面比较差异无统计学意义(P>0.05);合并高血压病、eGFR、尿酸、白蛋白、血红蛋白、红细胞比容、纤维蛋白原、射血分数、急诊PCI术、术前使用他汀类和ACEI/ARB类药物等因素比较差异有统计学意义(P<0.05)。(2)多因素Logistic回归分析显示,合并高血压病(OR=4.605;95%CI:1.298,16.337;P=0.018)、术前未使用ACEI/ARB类药物(OR=0.399;95%CI:0.173,0.923;P=0.032)、急诊PCI术(OR=2.4;95%CI:1.055,5.463;P=0.037)、血尿酸升高(OR=1.005;95%CI:1.001,1.009;P=0.013)是老年糖尿病合并ACS患者PCI术后发生造影剂肾病的危险因素。结论:合并高血压病、术前未使用ACEI/ARB类药物、急诊PCI术、血尿酸升高会增加老年糖尿病合并ACS患者行PCI术后发生造影剂肾病的风险。 Objective:To investigate risk factors of contrast induced nephropathy(CIN)after percutaneous coronary intervention(PCI)in elderly diabetic patients.Method:A total of 257 elderly diabetic patients with acute coronary syndrome(ACS)underwent PCI admitter in department of cardiology from January to December 2018 were involved in this study.The patients were divided into two groups according to the presence or absence of contrast induced nephropathy.A total of 207 patients without CIN were selected as control group,and 50 patients with CIN were chosen as the observation group.The age,seuality,body mass index(BMI),pulse pressure,hypertention,blood glucose level,laboratory date,emergency PCI,premedicate and so on were compared between the two groups.Multifactor logistic regression analysis was used to find risk factors of CIN.Result:(1)There was no significant difference between the two groups in the indicators such as age,sexuality,BMI,pulse pressure,fasting blood glucose,2-hour post-meal blood glucose,glycosylated hemoglobin,blood fat,D-Dimer,operation time,contrast dose(P>0.05).There was a siginiicant difference in the indicators such as hypertention,eGFR,uric acid,albumin,hemoglobin,hemetokrit,fibrinogen,ejection fraction,emergency PCI,perioperative use of statins and ACEI/ARB(P<0.05).(2)Loistic regression analysis showed that hypertention(OR=4.605,95%CI:1.298,16.337,P=0.018),perioperetive unused of ACEI/ARB(OR=0.399,95%CI:0.173,0.923,P=0.032),emergency PCI(OR=2.4,95%CI:1.055,5.463,P=0.037)and hyperuricacidemia(OR=1.005,95%CI:1.001,1.009,P=0.013)were the risk factors of CIN for elderly diabetic patients with ACS after PCI.Conclusin:The risk of CIN was increased by hypertention,perioperetive unused of ACEI/ARB,emergency PCI and hyperuricacidemia in elderly diabetes patients with acuter coronary syndrome after PCI.
作者 陈洋鸿 陈巧玲 CHEN Yanghong;CHEN Qiaoling(Fujian Medical University Union Hospital,Fuzhou 350000,China)
出处 《中外医学研究》 2019年第36期1-4,共4页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 福建医科大学启航基金项目(项目编号:2016QH019)
关键词 老年糖尿病患者 经皮冠状动脉介入术 造影剂肾病 危险因素 Elderly diabetes mellitus patients Percutaneous coronary intervention Contrast induced nephropathy Risk factors
  • 相关文献

参考文献4

二级参考文献39

  • 1Yao-Min Hung,Shoa-Lin Lin,Shih-Yuan Hung,Paul Yung-Pou Wang.Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography[J].World Journal of Cardiology,2012,4(5):157-172. 被引量:12
  • 2Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after pereutaneous coronary intervention: development and initial validation. J Am Coil Cardio1,2004,44 : 1393-1399.
  • 3McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol,2006,98 (6A) :5K-13K.
  • 4Sceliger E, Sendeski M, Rihal CS, el al. Contrast-induced kidney injm'y: mechanisms, risk factors, and prevention. Eur Heart J ,2012,33:2007-2015.
  • 5Kay J, Chow WH, Chan TM, et al. Aeetylcysteine for prevention of acute deterioration of renal function following elective coronal7 angiography and intervention: a randomized eontrolled trial. JAMA ,2003,289:553-558.
  • 6Feig DI, Kang DH, Johnson RJ. Uric: acid and cardiovascular risk. N Engl J Med ,2008,359 : 1811-1821.
  • 7Short RA, Johnson RJ, Turtle KR. Uric acid, microalbuminuria and cardiovascular events in high-risk patients. Am J Nephrol, 2005,25:36~-4.
  • 8Kang DH, Nakagawa T. Uric acid and ehronic renal disease: possible implication of hyperurieemia on progression of renal disease. Semin Nephrol, 2005,25:43-49.
  • 9Madsen TE, Muhlestein JB, Carlquist JF, et al. Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease. Am J Nephrol,2005, 25:45-49.
  • 10Perlstein TS, Gumieniak O, Hopkins PN, et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney lnt,2004,66 : 1465-1470.

共引文献62

同被引文献39

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部